Crowley Michael 4
4 · BIO-RAD LABORATORIES, INC. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
BIO-RAD LABORATORIES, INC.BIO BIO.B
Crowley Michael
EVP, GBL Commercial Operations
Transactions
- Sale
Bio-Rad A Common Stock
2025-03-14$247.06/sh−3,000$741,184→ 8,171 total - Exercise/Conversion
Bio-Rad A Common Stock
2025-03-14$159.32/sh+3,000$477,960→ 11,171 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-03-14−3,000→ 0 totalExercise: $159.32Exp: 2026-09-07→ Bio-Rad A Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.0239 to $249.1550, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.